Document ID: chunk:federal_register_of_legislation:F2017L00467:clause:1_1:p1
Version: federal_register_of_legislation:F2017L00467
Segment Type: clause
Provision Reference: sch 1 cl 1 (pt 1/2)
Character Range: 11823–15834

1               Definitions
In this instrument:
                                  allergic bronchopulmonary aspergillosis means infection of the bronchi and lungs by species of Aspergillus accompanied by wheeze, often with expectoration of yellow or brown bronchial plugs composed of eosinophils and fungal hyphae.
                                  aspiration pneumonitis means inflammation of the lungs with clinical or radiological evidence of consolidation due to the deposition into the respiratory tract of a substance or material from the upper aerodigestive tract.
Note: Examples of a substance or material that may be deposited from the upper aerodigestive tract include food particles, oral secretions or gastric contents.
                                  being exposed to arsenic as specified means:
         (a)          consuming drinking water with an average arsenic concentration of at least 50 micrograms per litre for a cumulative period of at least ten years; or
         (b)          having clinical evidence of excessive chronic arsenic exposure.
                                  bronchial obstruction means partial or complete blockage of the lumen of a bronchus.
Note: Examples of a cause of bronchial obstruction include an inhaled foreign body, broncholith or neoplasm, extrinsic narrowing due to enlarged lymph nodes, twisting or displacement of the airways after a lobar resection, or middle lobe syndrome.
                                  bronchiectasis—see subsection 7(2).
                                  immunosuppressive drug means a drug or an agent which results in substantial suppression of immune responses.
Note: Examples of an immunosuppressive drug include corticosteroids other than inhaled or topical corticosteroids, drugs used to prevent transplant rejection, tumour necrosis factor-α inhibitors and chemotherapeutic agents used for the treatment of cancer.
                                  MRCA means the Military Rehabilitation and Compensation Act 2004.
                                  relevant service means:
         (a)          operational service under the VEA;
         (b)          peacekeeping service under the VEA;
         (c)          hazardous service under the VEA;
         (d)          British nuclear test defence service under the VEA;
         (e)          warlike service under the MRCA; or
         (f)           non-warlike service under the MRCA.
Note: MRCA and VEA are also defined in the Schedule 1 - Dictionary.

                                  severe and persistent asthma means asthma having any of the following specified characteristics, alone or in combination, for a cumulative period of at least six months within a continuous one year period:
         (a)          FEV1 (forced expiratory volume in one second) of 60% or less of expected value;
         (b)          wheeze, tightness, cough, dyspnoea or other symptoms occurring throughout each day;
         (c)          frequent flare-ups;
         (d)          the presence of night-time symptoms on more than one night per week; or
         (e)          symptoms frequently restrict activity or sleep.
                                  specified list of chemical agents means:
         (a)          ammonia;
         (b)          chlorine;
         (c)          oxides of nitrogen;
         (d)          oxides of sulphur;
         (e)          paraquat;
         (f)           phosgene; or
         (g)          smoke from fires.
                                  specified list of connective tissue diseases means:
         (a)          ankylosing spondylitis;
         (b)          dermatomyositis;
         (c)          eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome);
         (d)          granulomatosis with polyangiitis (Wegener's granulomatosis);
         (e)          microscopic polyangiitis;
         (f)           mixed connective tissue disease;
         (g)          polymyositis;
         (h)          relapsing polychondritis;